Publications by authors named "Alice Huntsman-Labed"

Claim this Profile
S
Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.
Ravi Savarirayan, Melita Irving, William R Wilcox, Carlos A Bacino, Julie E Hoover-Fong, Alice Huntsman-Labed

Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Ravi Savarirayan, Melita Irving, William R Wilcox, Carlos A Bacino, Julie E Hoover-Fong, Alice Huntsman-Labed

Genet Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
Ravi Savarirayan, William R Wilcox, Paul Harmatz, John Phillips, Lynda E Polgreen, Alice Huntsman-Labed

Lancet Child Adolesc Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.
Ravi Savarirayan, Melita Irving, Paul Harmatz, Borja Delgado, William R Wilcox, Alice Huntsman-Labed

Genet Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.
Ming Liang Chan, Yulan Qi, Kevin Larimore, Anu Cherukuri, Lori Seid, Alice Huntsman-Labed

Clin Pharmacokinet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.
Ravi Savarirayan, Louise Tofts, Melita Irving, William R Wilcox, Carlos A Bacino, Alice Huntsman-Labed

Genet Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.
Ravi Savarirayan, Louise Tofts, Melita Irving, William Wilcox, Carlos A Bacino, Alice Huntsman-Labed

Lancet· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
Ravi Savarirayan, Melita Irving, Carlos A Bacino, Bret Bostwick, Joel Charrow

N Engl J Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
Jason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, Cem Akin, Karl Sotlar

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
Adam del Corral, Catherine Dutreix, Alice Huntsman-Labed, Sebastien Lorenzo, Joel Morganroth

Cancer Chemother Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.
Thomas Fischer, Richard M Stone, Daniel J Deangelo, Ilene Galinsky, Elihu Estey, Alice Huntsman-Labed

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the most appropriate components for a composite clinical trial outcome.
M Angelyn Bethel, Rury Holman, Steven M Haffner, Robert M Califf, Alice Huntsman-Labed

Am Heart J· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis